APO Research
Talk to an analyst

APO RESEARCH · REPORT

Orphan Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Orphan Drugs Industry Growth and Trends Forecast to 2032

28 December 2025101 pages

Choose your research edition.

Industry ResearchOrphan Drugs Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Orphan Drugs Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Orphan Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Orphan Drugs Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Orphan Drugs Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

According to APO Research, the global Orphan Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Orphan Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Orphan Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Orphan Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Orphan Drugs market include AstraZeneca, AbbVie, Amgen, Bristol-Myers Squibb, Biogen, Vertex Pharmaceuticals, Pfizer, Eli Lilly and Roche, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Orphan Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Orphan Drugs market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Orphan Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Orphan Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Orphan Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Orphan Drugs Market by Company

AstraZeneca

AbbVie

Amgen

Bristol-Myers Squibb

Biogen

Vertex Pharmaceuticals

Pfizer

Eli Lilly

Roche

Novartis

Johnson & Johnson

Sanofi

Takeda

Orphan Drugs Segment by Type

Metabolic Disorders

Pulmonary

Endocrinology

Neurology

Cardio-vascular

Hematology

Oncology

Others

Orphan Drugs Segment by Application

Adult

Teenager

Baby and Child

Other

Orphan Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Orphan Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Orphan Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Orphan Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Orphan Drugs companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Orphan Drugs Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Orphan Drugs Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Orphan Drugs Market Share by Region (2021-2026) Table 4. Global Orphan Drugs Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Orphan Drugs Market Share by Region (2027-2032) Table 6. Global Orphan Drugs Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Orphan Drugs Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Orphan Drugs Market Size Share by Type (2021-2026) Table 9. Global Orphan Drugs Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Orphan Drugs Market Size Share Forecasted by Type (2027-2032) Table 11. North America Orphan Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Orphan Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Orphan Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Orphan Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Orphan Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Orphan Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Orphan Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Orphan Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Orphan Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Orphan Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Orphan Drugs Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Orphan Drugs Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Orphan Drugs Market Size Share by Application (2021-2026) Table 24. Global Orphan Drugs Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Orphan Drugs Market Size Share Forecasted by Application (2027-2032) Table 26. North America Orphan Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Orphan Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Orphan Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Orphan Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Orphan Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Orphan Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Orphan Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Orphan Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Orphan Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Orphan Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Orphan Drugs Industry Trends Table 37. Orphan Drugs Industry Drivers Table 38. Orphan Drugs Industry Opportunities and Challenges Table 39. Orphan Drugs Industry Restraints Table 40. Global Orphan Drugs Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Orphan Drugs Revenue Market Share by Company (2021-2026) Table 42. Global Orphan Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Orphan Drugs Key Company Headquarters & Area Served Table 44. Global Orphan Drugs Company, Product Type & Application Table 45. Global Orphan Drugs Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Orphan Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. AstraZeneca Company Information Table 49. AstraZeneca Business Overview Table 50. AstraZeneca Orphan Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. AstraZeneca Orphan Drugs Product Portfolio Table 52. AstraZeneca Recent Development Table 53. AbbVie Company Information Table 54. AbbVie Business Overview Table 55. AbbVie Orphan Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. AbbVie Orphan Drugs Product Portfolio Table 57. AbbVie Recent Development Table 58. Amgen Company Information Table 59. Amgen Business Overview Table 60. Amgen Orphan Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Amgen Orphan Drugs Product Portfolio Table 62. Amgen Recent Development Table 63. Bristol-Myers Squibb Company Information Table 64. Bristol-Myers Squibb Business Overview Table 65. Bristol-Myers Squibb Orphan Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Bristol-Myers Squibb Orphan Drugs Product Portfolio Table 67. Bristol-Myers Squibb Recent Development Table 68. Biogen Company Information Table 69. Biogen Business Overview Table 70. Biogen Orphan Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Biogen Orphan Drugs Product Portfolio Table 72. Biogen Recent Development Table 73. Vertex Pharmaceuticals Company Information Table 74. Vertex Pharmaceuticals Business Overview Table 75. Vertex Pharmaceuticals Orphan Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Vertex Pharmaceuticals Orphan Drugs Product Portfolio Table 77. Vertex Pharmaceuticals Recent Development Table 78. Pfizer Company Information Table 79. Pfizer Business Overview Table 80. Pfizer Orphan Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Pfizer Orphan Drugs Product Portfolio Table 82. Pfizer Recent Development Table 83. Eli Lilly Company Information Table 84. Eli Lilly Business Overview Table 85. Eli Lilly Orphan Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Eli Lilly Orphan Drugs Product Portfolio Table 87. Eli Lilly Recent Development Table 88. Roche Company Information Table 89. Roche Business Overview Table 90. Roche Orphan Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Roche Orphan Drugs Product Portfolio Table 92. Roche Recent Development Table 93. Novartis Company Information Table 94. Novartis Business Overview Table 95. Novartis Orphan Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Novartis Orphan Drugs Product Portfolio Table 97. Novartis Recent Development Table 98. Johnson & Johnson Company Information Table 99. Johnson & Johnson Business Overview Table 100. Johnson & Johnson Orphan Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Johnson & Johnson Orphan Drugs Product Portfolio Table 102. Johnson & Johnson Recent Development Table 103. Sanofi Company Information Table 104. Sanofi Business Overview Table 105. Sanofi Orphan Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Sanofi Orphan Drugs Product Portfolio Table 107. Sanofi Recent Development Table 108. Takeda Company Information Table 109. Takeda Business Overview Table 110. Takeda Orphan Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Takeda Orphan Drugs Product Portfolio Table 112. Takeda Recent Development Table 113. North America Orphan Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. North America Orphan Drugs Market Size by Country (2021-2026) & (US$ Million) Table 115. North America Orphan Drugs Market Share by Country (2021-2026) Table 116. North America Orphan Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. North America Orphan Drugs Market Share Forecast by Country (2027-2032) Table 118. Europe Orphan Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Europe Orphan Drugs Market Size by Country (2021-2026) & (US$ Million) Table 120. Europe Orphan Drugs Market Share by Country (2021-2026) Table 121. Europe Orphan Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Europe Orphan Drugs Market Share Forecast by Country (2027-2032) Table 123. Asia-Pacific Orphan Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Asia-Pacific Orphan Drugs Market Size by Country (2021-2026) & (US$ Million) Table 125. Asia-Pacific Orphan Drugs Market Share by Country (2021-2026) Table 126. Asia-Pacific Orphan Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Asia-Pacific Orphan Drugs Market Share Forecast by Country (2027-2032) Table 128. Latin America Orphan Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Latin America Orphan Drugs Market Size by Country (2021-2026) & (US$ Million) Table 130. Latin America Orphan Drugs Market Share by Country (2021-2026) Table 131. Latin America Orphan Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Latin America Orphan Drugs Market Share Forecast by Country (2027-2032) Table 133. Middle East & Africa Orphan Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Middle East & Africa Orphan Drugs Market Size by Country (2021-2026) & (US$ Million) Table 135. Middle East & Africa Orphan Drugs Market Share by Country (2021-2026) Table 136. Middle East & Africa Orphan Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Middle East & Africa Orphan Drugs Market Share Forecast by Country (2027-2032) Table 138. Research Programs/Design for This Report Table 139. Authors List of This Report Table 140. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Orphan Drugs Product Image Figure 3. Global Orphan Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Orphan Drugs Market Size (2021-2032) & (US$ Million) Figure 5. Global Orphan Drugs Market Share by Region: 2025 VS 2032 Figure 6. Global Orphan Drugs Market Share by Region (2021-2032) Figure 7. North America Orphan Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Orphan Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Orphan Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Orphan Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Orphan Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Metabolic Disorders Image Figure 13. Global Metabolic Disorders Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Pulmonary Image Figure 15. Global Pulmonary Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Endocrinology Image Figure 17. Global Endocrinology Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Neurology Image Figure 19. Global Neurology Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Cardio-vascular Image Figure 21. Global Cardio-vascular Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Hematology Image Figure 23. Global Hematology Market Size YoY Growth (2021-2032) & (US$ Million) Figure 24. Oncology Image Figure 25. Global Oncology Market Size YoY Growth (2021-2032) & (US$ Million) Figure 26. Others Image Figure 27. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 28. Global Orphan Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 29. Global Orphan Drugs Market Share by Type 2025 VS 2032 Figure 30. North America Orphan Drugs Market Size Share by Type (2021-2032) Figure 31. Europe Orphan Drugs Market Size Share by Type (2021-2032) Figure 32. Asia-Pacific Orphan Drugs Market Size Share by Type (2021-2032) Figure 33. Latin America Orphan Drugs Market Size Share by Type (2021-2032) Figure 34. Middle East and Africa Orphan Drugs Market Size Share by Type (2021-2032) Figure 35. Adult Image Figure 36. Global Adult Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Teenager Image Figure 38. Global Teenager Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Baby and Child Image Figure 40. Global Baby and Child Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. Other Image Figure 42. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 43. Global Orphan Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 44. Global Orphan Drugs Market Share by Application 2025 VS 2032 Figure 45. North America Orphan Drugs Market Size Share by Application (2021-2032) Figure 46. Europe Orphan Drugs Market Size Share by Application (2021-2032) Figure 47. Asia-Pacific Orphan Drugs Market Size Share by Application (2021-2032) Figure 48. Latin America Orphan Drugs Market Size Share by Application (2021-2032) Figure 49. Middle East and Africa Orphan Drugs Market Size Share by Application (2021-2032) Figure 50. Global Top 5 and 10 Orphan Drugs Players Market Share by Revenue in 2025 Figure 51. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 52. North America Orphan Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. North America Orphan Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. North America Orphan Drugs Market Share by Country (2021-2032) Figure 55. Europe Orphan Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Orphan Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Orphan Drugs Market Share by Country (2021-2032) Figure 58. Asia-Pacific Orphan Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Asia-Pacific Orphan Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Orphan Drugs Market Share by Country (2021-2032) Figure 61. Latin America Orphan Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Orphan Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Orphan Drugs Market Share by Country (2021-2032) Figure 64. Middle East & Africa Orphan Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 65. Middle East & Africa Orphan Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 66. Middle East & Africa Orphan Drugs Market Share by Country (2021-2032) Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Metabolic Disorders
  • Pulmonary
  • Endocrinology
  • Neurology
  • Cardio-vascular
  • Hematology
  • Oncology
  • Others
Applications
  • Adult
  • Teenager
  • Baby and Child
  • Other
Companies covered
  • AstraZeneca
  • AbbVie
  • Amgen
  • Bristol-Myers Squibb
  • Biogen
  • Vertex Pharmaceuticals
  • Pfizer
  • Eli Lilly
  • Roche
  • Novartis
  • Johnson & Johnson
  • Sanofi
  • Takeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Orphan Drugs Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Orphan Drugs Market Size by Region (2021-2032)
  5. 1.4.1 Global Orphan Drugs Market Size by Region (2021-2026)
  6. 1.4.2 Global Orphan Drugs Market Size by Region (2027-2032)
  7. 1.5 Key Regions Orphan Drugs Market Size (2021-2032)
  8. 1.5.1 North America Orphan Drugs Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Orphan Drugs Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Orphan Drugs Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Orphan Drugs Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Orphan Drugs Market Size Growth Rate (2021-2032)
2 Orphan Drugs Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Metabolic Disorders
  3. 2.1.2 Pulmonary
  4. 2.1.3 Endocrinology
  5. 2.1.4 Neurology
  6. 2.1.5 Cardio-vascular
  7. 2.1.6 Hematology
  8. 2.1.7 Oncology
  9. 2.1.8 Others
  10. 2.2 Global Orphan Drugs Market Size by Type
  11. 2.2.1 Global Orphan Drugs Market Size Overview by Type (2021-2032)
  12. 2.2.2 Global Orphan Drugs Historic Market Size Review by Type (2021-2026)
  13. 2.2.3 Global Orphan Drugs Market Size Forecasted by Type (2027-2032)
  14. 2.3 Global Orphan Drugs Market Size by Regions
  15. 2.3.1 North America Orphan Drugs Market Size Breakdown by Type (2021-2026)
  16. 2.3.2 Europe Orphan Drugs Market Size Breakdown by Type (2021-2026)
  17. 2.3.3 Asia-Pacific Orphan Drugs Market Size Breakdown by Type (2021-2026)
  18. 2.3.4 South America Orphan Drugs Market Size Breakdown by Type (2021-2026)
  19. 2.3.5 Middle East and Africa Orphan Drugs Market Size Breakdown by Type (2021-2026)
3 Orphan Drugs Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Adult
  3. 3.1.2 Teenager
  4. 3.1.3 Baby and Child
  5. 3.1.4 Other
  6. 3.2 Global Orphan Drugs Market Size by Application
  7. 3.2.1 Global Orphan Drugs Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Orphan Drugs Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Orphan Drugs Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Orphan Drugs Market Size by Regions
  11. 3.3.1 North America Orphan Drugs Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Orphan Drugs Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Orphan Drugs Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Orphan Drugs Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Orphan Drugs Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Orphan Drugs Industry Trends
  2. 4.2 Orphan Drugs Industry Drivers
  3. 4.3 Orphan Drugs Industry Opportunities and Challenges
  4. 4.4 Orphan Drugs Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Orphan Drugs Revenue (2021-2026)
  2. 5.2 Global Orphan Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Orphan Drugs Key Company Headquarters & Area Served
  4. 5.4 Global Orphan Drugs Company, Product Type & Application
  5. 5.5 Global Orphan Drugs Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Orphan Drugs Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Orphan Drugs Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Orphan Drugs Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 AstraZeneca
  2. 6.1.1 AstraZeneca Company Information
  3. 6.1.2 AstraZeneca Business Overview
  4. 6.1.3 AstraZeneca Orphan Drugs Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 AstraZeneca Orphan Drugs Product Portfolio
  6. 6.1.5 AstraZeneca Recent Developments
  7. 6.2 AbbVie
  8. 6.2.1 AbbVie Company Information
  9. 6.2.2 AbbVie Business Overview
  10. 6.2.3 AbbVie Orphan Drugs Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 AbbVie Orphan Drugs Product Portfolio
  12. 6.2.5 AbbVie Recent Developments
  13. 6.3 Amgen
  14. 6.3.1 Amgen Company Information
  15. 6.3.2 Amgen Business Overview
  16. 6.3.3 Amgen Orphan Drugs Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Amgen Orphan Drugs Product Portfolio
  18. 6.3.5 Amgen Recent Developments
  19. 6.4 Bristol-Myers Squibb
  20. 6.4.1 Bristol-Myers Squibb Company Information
  21. 6.4.2 Bristol-Myers Squibb Business Overview
  22. 6.4.3 Bristol-Myers Squibb Orphan Drugs Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Bristol-Myers Squibb Orphan Drugs Product Portfolio
  24. 6.4.5 Bristol-Myers Squibb Recent Developments
  25. 6.5 Biogen
  26. 6.5.1 Biogen Company Information
  27. 6.5.2 Biogen Business Overview
  28. 6.5.3 Biogen Orphan Drugs Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Biogen Orphan Drugs Product Portfolio
  30. 6.5.5 Biogen Recent Developments
  31. 6.6 Vertex Pharmaceuticals
  32. 6.6.1 Vertex Pharmaceuticals Company Information
  33. 6.6.2 Vertex Pharmaceuticals Business Overview
  34. 6.6.3 Vertex Pharmaceuticals Orphan Drugs Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Vertex Pharmaceuticals Orphan Drugs Product Portfolio
  36. 6.6.5 Vertex Pharmaceuticals Recent Developments
  37. 6.7 Pfizer
  38. 6.7.1 Pfizer Company Information
  39. 6.7.2 Pfizer Business Overview
  40. 6.7.3 Pfizer Orphan Drugs Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Pfizer Orphan Drugs Product Portfolio
  42. 6.7.5 Pfizer Recent Developments
  43. 6.8 Eli Lilly
  44. 6.8.1 Eli Lilly Company Information
  45. 6.8.2 Eli Lilly Business Overview
  46. 6.8.3 Eli Lilly Orphan Drugs Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Eli Lilly Orphan Drugs Product Portfolio
  48. 6.8.5 Eli Lilly Recent Developments
  49. 6.9 Roche
  50. 6.9.1 Roche Company Information
  51. 6.9.2 Roche Business Overview
  52. 6.9.3 Roche Orphan Drugs Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Roche Orphan Drugs Product Portfolio
  54. 6.9.5 Roche Recent Developments
  55. 6.10 Novartis
  56. 6.10.1 Novartis Company Information
  57. 6.10.2 Novartis Business Overview
  58. 6.10.3 Novartis Orphan Drugs Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Novartis Orphan Drugs Product Portfolio
  60. 6.10.5 Novartis Recent Developments
  61. 6.11 Johnson & Johnson
  62. 6.11.1 Johnson & Johnson Company Information
  63. 6.11.2 Johnson & Johnson Business Overview
  64. 6.11.3 Johnson & Johnson Orphan Drugs Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Johnson & Johnson Orphan Drugs Product Portfolio
  66. 6.11.5 Johnson & Johnson Recent Developments
  67. 6.12 Sanofi
  68. 6.12.1 Sanofi Company Information
  69. 6.12.2 Sanofi Business Overview
  70. 6.12.3 Sanofi Orphan Drugs Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Sanofi Orphan Drugs Product Portfolio
  72. 6.12.5 Sanofi Recent Developments
  73. 6.13 Takeda
  74. 6.13.1 Takeda Company Information
  75. 6.13.2 Takeda Business Overview
  76. 6.13.3 Takeda Orphan Drugs Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Takeda Orphan Drugs Product Portfolio
  78. 6.13.5 Takeda Recent Developments
7 North America
  1. 7.1 North America Orphan Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Orphan Drugs Market Size by Country (2021-2026)
  3. 7.3 North America Orphan Drugs Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Orphan Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Orphan Drugs Market Size by Country (2021-2026)
  3. 8.3 Europe Orphan Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Orphan Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Orphan Drugs Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Orphan Drugs Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Orphan Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Orphan Drugs Market Size by Country (2021-2026)
  3. 10.3 South America Orphan Drugs Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Orphan Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Orphan Drugs Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Orphan Drugs Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst